These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 38700023)
1. Maternal opioid use during pregnancy and the risk of neonatal opioid withdrawal syndrome in the offspring. Kristensen AW; Vestermark V; Kjærbye-Thygesen A; Eckhardt MC; Kesmodel US Acta Obstet Gynecol Scand; 2024 Aug; 103(8):1522-1529. PubMed ID: 38700023 [TBL] [Abstract][Full Text] [Related]
2. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns. Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312 [TBL] [Abstract][Full Text] [Related]
3. Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone. Petrich M; Battin M; Walker E; Brown M; Abdelwahab M; Ma'ayeh M; Rood KM J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10481-10486. PubMed ID: 36202398 [TBL] [Abstract][Full Text] [Related]
4. Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age. Bakhireva LN; Holbrook BD; Shrestha S; Leyva Y; Ashley M; Cano S; Lowe J; Stephen JM; Leeman L Early Hum Dev; 2019 Jan; 128():69-76. PubMed ID: 30554024 [TBL] [Abstract][Full Text] [Related]
5. Neonatal opioid toxicity: opioid withdrawal (abstinence) syndrome with emphasis on pharmacogenomics and respiratory depression. Baldo BA Arch Toxicol; 2023 Oct; 97(10):2575-2585. PubMed ID: 37537419 [TBL] [Abstract][Full Text] [Related]
6. Duration and Timing of In Utero Opioid Exposure and Incidence of Neonatal Withdrawal Syndrome. Wang Y; Berger L; Durrance C; Kirby RS; Kuo D; Pac J; Ehrenthal DB Obstet Gynecol; 2023 Sep; 142(3):603-611. PubMed ID: 37548391 [TBL] [Abstract][Full Text] [Related]
7. Trajectories of Prescription Opioid Utilization During Pregnancy Among Prepregnancy Chronic Users and Risk of Neonatal Opioid Withdrawal Syndrome. Straub L; Huybrechts KF; Hernández-Díaz S; Zhu Y; Vine S; Desai RJ; Gray KJ; Bateman BT Am J Epidemiol; 2022 Jan; 191(1):208-219. PubMed ID: 34643225 [TBL] [Abstract][Full Text] [Related]
8. Prenatal Use of Medication for Opioid Use Disorder and Other Prescription Opioids in Cases of Neonatal Opioid Withdrawal Syndrome: North Carolina Medicaid, 2016-2018. Austin AE; Bona VD; Cox ME; Proescholdbell S; Fliss MD; Naumann RB Am J Public Health; 2021 Sep; 111(9):1682-1685. PubMed ID: 34383554 [No Abstract] [Full Text] [Related]
9. Transplacental methadone exposure and risk of Neonatal Opioid Withdrawal Syndrome. Bhatt-Mehta V; Jing X; Wang X; Zhu HJ Pharmacotherapy; 2024 Jan; 44(1):22-27. PubMed ID: 37574548 [TBL] [Abstract][Full Text] [Related]
10. Newborn Cry Acoustics in the Assessment of Neonatal Opioid Withdrawal Syndrome Using Machine Learning. Manigault AW; Sheinkopf SJ; Silverman HF; Lester BM JAMA Netw Open; 2022 Oct; 5(10):e2238783. PubMed ID: 36301544 [TBL] [Abstract][Full Text] [Related]
11. Assessing Neonatal Opioid Withdrawal Syndrome Severity as a Function of Maternal Buprenorphine Dose and Umbilical Cord Tissue Concentrations. Rana D; McLeod AR; Gaston PK; Hill DM; Pourcyrous M Ann Pharmacother; 2023 Aug; 57(8):892-898. PubMed ID: 36321504 [TBL] [Abstract][Full Text] [Related]
12. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study. Desai RJ; Huybrechts KF; Hernandez-Diaz S; Mogun H; Patorno E; Kaltenbach K; Kerzner LS; Bateman BT BMJ; 2015 May; 350():h2102. PubMed ID: 25975601 [TBL] [Abstract][Full Text] [Related]
13. Maternal Opioid Use Disorder and the Risk of Postneonatal Infant Mortality. Grossarth S; Osmundson SS; Wiese AD; Phillips SE; Pham A; Leech AA; Patrick SW; Spieker AJ; Grijalva CG; Adgent MA JAMA Pediatr; 2023 Jul; 177(7):675-683. PubMed ID: 37155175 [TBL] [Abstract][Full Text] [Related]
14. Impact of In-utero Exposure to Selective Serotonin Reuptake Inhibitors and Opioids on Neonatal Opioid Withdrawal Syndrome. Bhatt-Mehta V; Richards J; Sturza J; Schumacher RE J Addict Med; 2019; 13(3):227-234. PubMed ID: 30489344 [TBL] [Abstract][Full Text] [Related]
15. Maternal and iatrogenic neonatal opioid withdrawal syndrome: Differences and similarities in recognition, management, and consequences. Isaac L; van den Hoogen NJ; Habib S; Trang T J Neurosci Res; 2022 Jan; 100(1):373-395. PubMed ID: 33675100 [TBL] [Abstract][Full Text] [Related]
16. Severe Neonatal Opioid Withdrawal Requiring Pharmacotherapy: Impact of Region of Residence. Sankaran D; Rawat S; Kachelmeyer JL; Li ES; Reynolds AM; Rawat M; Chandrasekharan P Am J Perinatol; 2024 May; 41(S 01):e654-e663. PubMed ID: 35973797 [TBL] [Abstract][Full Text] [Related]